{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:59:15Z","timestamp":1785441555260,"version":"3.56.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12508-0","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:51:23Z","timestamp":1785394283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From veterinary antibiotic to cancer therapy: revisiting anticancer potential of Monensin"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9924-3541","authenticated-orcid":false,"given":"Ali","family":"Darabniya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Shahriari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad Jalilpour","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakiba","family":"Sheikholeslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"4","key":"12508_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/cancers13040806","volume":"13","author":"N El-Sayes","year":"2021","unstructured":"El-Sayes N, Vito A, Mossman K (2021) Tumor heterogeneity: a great barrier in the age of cancer immunotherapy. Cancers (Basel) 13(4):806. https:\/\/doi.org\/10.3390\/cancers13040806 PMID: 33671881; PMCID: PMC7918981","journal-title":"Cancers (Basel)"},{"issue":"22","key":"12508_CR2","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.2174\/1568026619666181129141151","volume":"18","author":"V Rajendran","year":"2018","unstructured":"Rajendran V, Ilamathi HS, Dutt S, Lakshminarayana TS, Ghosh PC (2018) Chemotherapeutic potential of monensin as an anti-microbial agent. Curr Top Med Chem 18(22):1976\u20131986","journal-title":"Curr Top Med Chem"},{"key":"12508_CR3","doi-asserted-by":"crossref","unstructured":"Aowicki D, Huczy\u0144ski A (2013) Structure and antimicrobial properties of monensin A and its derivatives: summary of the achievements. Biomed Res Int. ;2013:742149. doi: 10.1155\/2013\/742149. Epub 2013 Feb 13. PMID: 23509771; PMCID: PMC3586448","DOI":"10.1155\/2013\/742149"},{"key":"12508_CR4","doi-asserted-by":"publisher","unstructured":"Souza AC, Machado FS, Celes MR, Faria G, Rocha LB, Silva JS, Rossi MA (2005) Mitochondrial damage as an early event of monensin-induced cell injury in cultured fibroblasts L929. J Vet Med A Physiol Pathol Clin Med. ;52(5):230-7. https:\/\/doi.org\/10.1111\/j.1439-0442.2005.00728.x. PMID: 15943607","DOI":"10.1111\/j.1439-0442.2005.00728.x"},{"issue":"2\u20133","key":"12508_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.etp.2006.06.006","volume":"58","author":"M Singh","year":"2006","unstructured":"Singh M, Kalla NR, Sanyal SN (2006) Effect of monensin on the enzymes of oxidative stress, thiamine pyrophosphatase and DNA integrity in rat testicular cells in vitro. Exp Toxicol Pathol 58(2\u20133):203\u2013208. https:\/\/doi.org\/10.1016\/j.etp.2006.06.006 Epub 2006 Aug 14. PMID: 16905301","journal-title":"Exp Toxicol Pathol"},{"key":"12508_CR6","doi-asserted-by":"publisher","unstructured":"Dayekh K, Johnson-Obaseki S, Corsten M, Villeneuve PJ, Sekhon HS, Weberpals JI, Dimitroulakos J (2014) Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors. Mol Cancer Ther. ;13(11):2559-71. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-1086. Epub 2014 Sep 4. PMID: 25189541","DOI":"10.1158\/1535-7163.MCT-13-1086"},{"issue":"3","key":"12508_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/antibiotics12030546","volume":"12","author":"S Serter Kocoglu","year":"2023","unstructured":"Serter Kocoglu S, Secme M, Oy C, Korkusuz G, Elmas L (2023) Monensin, an antibiotic isolated from streptomyces cinnamonensis, regulates human neuroblastoma cell proliferation via the PI3K\/AKT signaling pathway and acts synergistically with rapamycin. Antibiot (Basel) 12(3):546. https:\/\/doi.org\/10.3390\/antibiotics12030546 PMID: 36978413; PMCID: PMC10044236","journal-title":"Antibiot (Basel)"},{"issue":"1","key":"12508_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4196\/kjpp.2024.28.1.21","volume":"28","author":"B Fu","year":"2024","unstructured":"Fu B, Fang L, Wang R, Zhang X (2024) Inhibition of Wnt\/\u03b2-catenin signaling by monensin in cervical cancer. Korean J Physiol Pharmacol 28(1):21\u201330 PMID: 38154961; PMCID: PMC10762490","journal-title":"Korean J Physiol Pharmacol"},{"issue":"1","key":"12508_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41598-018-38019-y","volume":"9","author":"M Vanneste","year":"2019","unstructured":"Vanneste M, Huang Q, Li M, Moose D, Zhao L, Stamnes MA, Schultz M, Wu M, Henry MD (2019) High content screening identifies monensin as an EMT-selective cytotoxic compound. Sci Rep 9(1):1200. https:\/\/doi.org\/10.1038\/s41598-018-38019-y PMID: 30718715; PMCID: PMC6361972","journal-title":"Sci Rep"},{"issue":"28","key":"12508_CR10","doi-asserted-by":"publisher","first-page":"e2501347122","DOI":"10.1073\/pnas.2501347122","volume":"122","author":"X Tan","year":"2025","unstructured":"Tan X, Cardin DL, Wang S, Xu Y, Russell WK (2025) Monensin suppresses EMT-driven cancer cell motility by inducing Golgi pH-dependent exocytosis of GOLIM4. Proc Natl Acad Sci U S A 122(28):e2501347122. https:\/\/doi.org\/10.1073\/pnas.2501347122 Epub 2025 Jul 9. PMID: 40632561; PMCID: PMC12280883","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12508_CR11","doi-asserted-by":"publisher","unstructured":"Ling Y, Priebe W, Perezsoler R (1993) Intrinsic cytotoxicity and reversal of multidrug-resistance by monensin in kb parent and mdr cells. Int J Oncol. ;3(5):971-7. https:\/\/doi.org\/10.3892\/ijo.3.5.971. PMID: 21573461","DOI":"10.3892\/ijo.3.5.971"},{"issue":"2","key":"12508_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10549-024-07374-y","volume":"207","author":"T Fang","year":"2024","unstructured":"Fang T, Hu S, Song X, Wang J, Zuo R, Yun S, Jiang S, Guo D (2024) Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways. Breast Cancer Res Treat 207(2):435\u2013451","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"12508_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13181-017-0616-6","volume":"13","author":"M Blain","year":"2017","unstructured":"Blain M, Garrard A, Poppenga R, Chen B, Valento M, Halliday Gittinger M (2017) Survival after severe rhabdomyolysis following monensin ingestion. J Med Toxicol 13(3):259\u2013262","journal-title":"J Med Toxicol"},{"issue":"2","key":"12508_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1128\/CMR.16.2.175-188.2003","volume":"16","author":"P Butaye","year":"2003","unstructured":"Butaye P, Devriese LA, Haesebrouck F (2003) Antimicrobial growth promoters used in animal feed: effects of less well-known antibiotics on gram-positive bacteria. Clin Microbiol Rev 16(2):175\u2013188 PMID: 12692092; PMCID: PMC153145","journal-title":"Clin Microbiol Rev"},{"key":"12508_CR15","doi-asserted-by":"publisher","first-page":"105861","DOI":"10.1016\/j.phrs.2021.105861","volume":"175","author":"M Zhang","year":"2022","unstructured":"Zhang M, Xu N, Xu W, Ling G, Zhang P (2022) Potential therapies and diagnosis based on Golgi-targeted nano drug delivery systems. Pharmacol Res 175:105861. https:\/\/doi.org\/10.1016\/j.phrs.2021.105861 Epub 2021 Aug 28. PMID: 34464677","journal-title":"Pharmacol Res"},{"key":"12508_CR16","doi-asserted-by":"publisher","unstructured":"Melroy D, Jones RL (1986) The effect of monensin on intracellular transport and secretion of \u03b1-amylase isoenzymes in barley aleurone. Planta. ;167(2):252-9. https:\/\/doi.org\/10.1007\/BF00391423. PMID: 24241859","DOI":"10.1007\/BF00391423"},{"issue":"1","key":"12508_CR17","first-page":"15","volume":"26","author":"HH Mollenhauer","year":"1984","unstructured":"Mollenhauer HH, Rowe LD, Witzel DA (1984) Effect of monensin on the morphology of mitochondria in rodent and equine striated muscle. Vet Hum Toxicol 26(1):15\u201319 PMID: 6702095","journal-title":"Vet Hum Toxicol"},{"issue":"16","key":"12508_CR18","doi-asserted-by":"publisher","first-page":"e35989","DOI":"10.1016\/j.heliyon.2024.e35989","volume":"10","author":"X Zhao","year":"2024","unstructured":"Zhao X, Ma Y, Luo J, Xu K, Tian P, Lu C, Song J (2024) Blocking the WNT\/\u03b2-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential. Heliyon 10(16):e35989 PMID: 39253139; PMCID: PMC11381626","journal-title":"Heliyon"},{"issue":"4","key":"12508_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1158\/1535-7163.MCT-13-0625","volume":"13","author":"L Tumova","year":"2014","unstructured":"Tumova L, Pombinho AR, Vojtechova M, Stancikova J, Gradl D, Krausova M, Sloncova E, Horazna M, Kriz V, Machonova O, Jindrich J, Zdrahal Z, Bartunek P, Korinek V (2014) Monensin inhibits canonical Wnt signaling in human colorectal cancer cells and suppresses tumor growth in multiple intestinal neoplasia mice. Mol Cancer Ther 13(4):812\u2013822. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0625 Epub 2014 Feb 19. PMID: 24552772","journal-title":"Mol Cancer Ther"},{"key":"12508_CR20","doi-asserted-by":"publisher","first-page":"22997","DOI":"10.1038\/srep22997","volume":"6","author":"RA Charvat","year":"2016","unstructured":"Charvat RA, Arrizabalaga G (2016) Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function. Sci Rep 6:22997. https:\/\/doi.org\/10.1038\/srep22997 PMID: 26976749; PMCID: PMC4792157","journal-title":"Sci Rep"},{"key":"12508_CR21","doi-asserted-by":"publisher","unstructured":"Dragwidge JM, Scholl S, Schumacher K, Gendall AR (2019) NHX-type Na+(K+)\/H+ antiporters are required for TGN\/EE trafficking and endosomal ion homeostasis in Arabidopsis thaliana. J Cell Sci. ;132(7):jcs226472. https:\/\/doi.org\/10.1242\/jcs.226472. PMID: 30837286","DOI":"10.1242\/jcs.226472"},{"key":"12508_CR22","doi-asserted-by":"publisher","unstructured":"Li Y, Sun Q, Chen S, Yu X, Jing H (2022) Monensin inhibits anaplastic thyroid cancer via disrupting mitochondrial respiration and AMPK\/mTOR signaling. Anticancer Agents Med Chem. ;22(14):2539\u20132547. https:\/\/doi.org\/10.2174\/1871520622666220215123620. PMID: 35168524","DOI":"10.2174\/1871520622666220215123620"},{"key":"12508_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.12.018","volume":"158","author":"F Xu","year":"2018","unstructured":"Xu F, Zhong H, Chang Y, Li D, Jin H, Zhang M, Wang H, Jiang C, Shen Y, Huang Y (2018) Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites. Biomaterials 158:56\u201373 Epub 2017 Dec 22. PMID: 29304403","journal-title":"Biomaterials"},{"key":"12508_CR24","doi-asserted-by":"publisher","unstructured":"Urbaniak A, Heflin B, Siegel E, Reed MR, Nix JS, Yee EU, J\u0119drzejczyk M, Klejborowska G, St\u0119pczy\u0144ska N, Huczy\u0144ski A, Nagalo MB, Chambers TC, Post S, Eoff RL, MacNicol MC, Tiwari AK, Kelly T, Tackett AJ, MacNicol AM (2025) Monensin and its analogs exhibit activity against breast cancer stem-like cells in an organoid model. bioRxiv [Preprint]. 9. . PMID: 40672259; PMCID: PMC12265528 https:\/\/doi.org\/10.1101\/2025.07.05.663311. PMID: 40672259; PMCID: PMC12265528.","DOI":"10.1101\/2025.07.05.663311"},{"issue":"3","key":"12508_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/cells14030185","volume":"14","author":"S Fiorilla","year":"2025","unstructured":"Fiorilla S, Tasso F, Clemente N, Trisciuoglio T, Boldorini R, Carini R (2025) Monensin inhibits triple-negative breast cancer in mice by a Na+-dependent cytotoxic action unrelated to cytostatic effects. Cells 14(3):185. https:\/\/doi.org\/10.3390\/cells14030185 PMID: 39936977; PMCID: PMC11817484","journal-title":"Cells"},{"key":"12508_CR26","doi-asserted-by":"crossref","unstructured":"Yang J, Cui Y TM9SF3 is a mammalian Golgiphagy receptor that safeguards Golgi integrity and glycosylation fidelity. Autophagy. 2025 Jul 28:1\u20132. Doi: 10.1080\/15548627.2025.2539928. Epub ahead of print. PMID: 40709739","DOI":"10.1080\/15548627.2025.2539928"},{"key":"12508_CR27","doi-asserted-by":"publisher","unstructured":"Fang T, Hu S, Song X, Wang J, Zuo R, Yun S, Jiang S, Guo D (2024) Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways. Breast Cancer Res Treat. ;207(2):435\u2013451. https:\/\/doi.org\/10.1007\/s10549-024-07374-y. Epub 2024 Jul 3. PMID: 38958784","DOI":"10.1007\/s10549-024-07374-y"},{"issue":"11","key":"12508_CR28","doi-asserted-by":"publisher","first-page":"e2204747","DOI":"10.1002\/smll.202204747","volume":"19","author":"L Chen","year":"2023","unstructured":"Chen L, Jiang P, Shen X, Lyu J, Liu C, Li L, Huang Y (2023) Cascade delivery to golgi apparatus and on-site formation of subcellular drug reservoir for cancer metastasis suppression. Small 19(11):e2204747. https:\/\/doi.org\/10.1002\/smll.202204747 Epub 2022 Dec 30. PMID: 36585358","journal-title":"Small"},{"issue":"17","key":"12508_CR29","doi-asserted-by":"publisher","first-page":"jcs260934","DOI":"10.1242\/jcs.260934","volume":"136","author":"M Marjanovi\u0107","year":"2023","unstructured":"Marjanovi\u0107 M, Mikecin Dra\u017ei\u0107 AM, Mio\u010d M, Parad\u017eik M, Kli\u010dek F, Novokmet M, Lauc G, Kralj M (2023) Salinomycin disturbs Golgi function and specifically affects cells in epithelial-to-mesenchymal transition. J Cell Sci 136(17):jcs260934. https:\/\/doi.org\/10.1242\/jcs.260934 Epub 2023 Sep 1. PMID: 37545292","journal-title":"J Cell Sci"},{"issue":"2","key":"12508_CR30","doi-asserted-by":"publisher","first-page":"113852","DOI":"10.1016\/j.yexcr.2023.113852","volume":"433","author":"SV Silva","year":"2023","unstructured":"Silva SV, Lima MA, Hodgson L, Freitas VM, Rodr\u00edguez-Manzaneque JC (2023) ADAMTS-1 has nuclear localization in cells with epithelial origin and leads to decreased cell migration. Exp Cell Res 433(2):113852. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113852 Epub 2023 Nov 10. PMID: 37951335; PMCID: PMC10841765","journal-title":"Exp Cell Res"},{"issue":"6","key":"12508_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/ddr.21683","volume":"81","author":"J Gu","year":"2020","unstructured":"Gu J, Huang L, Zhang Y (2020) Monensin inhibits proliferation, migration, and promotes apoptosis of breast cancer cells via downregulating UBA2. Drug Dev Res 81(6):745\u2013753. https:\/\/doi.org\/10.1002\/ddr.21683 Epub 2020 May 27. PMID: 32462716","journal-title":"Drug Dev Res"},{"issue":"2","key":"12508_CR32","doi-asserted-by":"publisher","first-page":"e0191270","DOI":"10.1371\/journal.pone.0191270","volume":"13","author":"T Russo-Abrah\u00e3o","year":"2018","unstructured":"Russo-Abrah\u00e3o T, Lacerda-Abreu MA, Gomes T, Cosentino-Gomes D, Carvalho-de-Ara\u00fajo AD, Rodrigues MF, Oliveira ACL, Rumjanek FD, Monteiro RQ, Meyer-Fernandes JR (2018) Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231. PLoS ONE 13(2):e0191270. https:\/\/doi.org\/10.1371\/journal.pone.0191270 PMID: 29415049; PMCID: PMC5802448","journal-title":"PLoS ONE"},{"key":"12508_CR33","doi-asserted-by":"publisher","unstructured":"Ketola K, Vainio P, Fey V, Kallioniemi O, Iljin K (2010) Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells. Mol Cancer Ther. ;9(12):3175-85. https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-0368. PMID: 21159605","DOI":"10.1158\/1535-7163.MCT-10-0368"},{"issue":"11","key":"12508_CR34","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.21873\/anticanres.11168","volume":"36","author":"SH Kim","year":"2016","unstructured":"Kim SH, Kim KY, Yu SN, Park SG, Yu HS, Seo YK, Ahn SC (2016) Monensin induces PC-3 prostate cancer cell apoptosis via ROS production and Ca2\u2009+\u2009homeostasis disruption. Anticancer Res 36(11):5835\u20135843","journal-title":"Anticancer Res"},{"key":"12508_CR35","unstructured":"Ye Z, Rohde LH, Wu H (2008) Radio-sensitization of prostate cancer cells by monensin treatment and its associated gene expression profiling changes. In54th Annual Meeting of the Radiation Research Society. Jan 1"},{"issue":"11Supplement","key":"12508_CR36","doi-asserted-by":"publisher","first-page":"A62","DOI":"10.1158\/1535-7163.TARG-11-A62","volume":"10","author":"K Ketola","year":"2011","unstructured":"Ketola K, Vuoristo A, Oresic M, Kallioniemi O, Iljin K (2011) Abstract A62: Monensin-induced oxidative stress reduces prostate cancer cell motility and cancer stem cell markers. Mol Cancer Ther 10(11Supplement):A62","journal-title":"Mol Cancer Ther"},{"key":"12508_CR37","doi-asserted-by":"publisher","unstructured":"Se\u00e7me M, Kocoglu SS (2023) Investigation of the TLR4 and IRF3 signaling pathway-mediated effects of monensin in colorectal cancer cells. Med Oncol. ;40(7):187. https:\/\/doi.org\/10.1007\/s12032-023-02055-0. PMID: 37219624","DOI":"10.1007\/s12032-023-02055-0"},{"issue":"1","key":"12508_CR38","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1080\/07853890.2023.2166980","volume":"55","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Deng Y, Wang J, Yan Z, Wei Q, Ye J, Zhang J, He TC, Qiao M (2023) Effect of antibiotic monensin on cell proliferation and IGF1R signaling pathway in human colorectal cancer cells. Ann Med 55(1):954\u2013964 PMID: 36896461; PMCID: PMC10795625","journal-title":"Ann Med"},{"issue":"2","key":"12508_CR39","first-page":"377","volume":"22","author":"WH Park","year":"2003","unstructured":"Park WH, Kim ES, Jung CW, Kim BK, Lee YY (2003) Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis. Int J Oncol 22(2):377\u2013382 PMID: 12527937","journal-title":"Int J Oncol"},{"key":"12508_CR40","doi-asserted-by":"publisher","unstructured":"Owatari S, Akune S, Komatsu M, Ikeda R, Firth SD, Che XF, Yamamoto M, Tsujikawa K, Kitazono M, Ishizawa T, Takeuchi T, Aikou T, Mercer JF, Akiyama S, Furukawa T (2007) Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer. Cancer Res. ;67(10):4860-8. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3096. Erratum in: Cancer Res. 2007;67(13):6528. PMID: 17510416","DOI":"10.1158\/0008-5472.CAN-06-3096"},{"key":"12508_CR41","doi-asserted-by":"publisher","unstructured":"Miraglia E, Viarisio D, Riganti C, Costamagna C, Ghigo D, Bosia A (2005) Na+\/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin. Int J Cancer. ;115(6):924-9. https:\/\/doi.org\/10.1002\/ijc.20959. PMID: 15729714","DOI":"10.1002\/ijc.20959"},{"issue":"1\u20132","key":"12508_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.etp.2009.09.011","volume":"63","author":"R Paduch","year":"2011","unstructured":"Paduch R, Kandefer-Szersze\u0144 M (2011) Expression and activation of proteases in co-cultures. Exp Toxicol Pathol 63(1\u20132):79\u201387. https:\/\/doi.org\/10.1016\/j.etp.2009.09.011 Epub 2009 Oct 17. PMID: 19836935","journal-title":"Exp Toxicol Pathol"},{"key":"12508_CR43","doi-asserted-by":"publisher","unstructured":"Griffin T, Rybak ME, Recht L, Singh M, Salimi A, Raso V (1993) Potentiation of antitumor immunotoxins by liposomal monensin. J Natl Cancer Inst. ;85(4):292-8. https:\/\/doi.org\/10.1093\/jnci\/85.4.292. PMID: 8426373","DOI":"10.1093\/jnci\/85.4.292"},{"key":"12508_CR44","doi-asserted-by":"publisher","unstructured":"Singh M, Griffin T, Salimi A, Micetich RG, Atwal H (1994) Potentiation of ricin A immunotoxin by monoclonal antibody targeted monensin containing small unilamellar vesicles. Cancer Lett. ;84(1):15\u201321. https:\/\/doi.org\/10.1016\/0304-3835(94)90353-0. PMID: 8076359","DOI":"10.1016\/0304-3835(94)90353-0"},{"issue":"4","key":"12508_CR45","first-page":"679","volume":"79","author":"TW Griffin","year":"1987","unstructured":"Griffin TW, Childs LR, FitzGerald DJ, Levin LV (1987) Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores. J Natl Cancer Inst 79(4):679\u2013685 PMID: 3498854","journal-title":"J Natl Cancer Inst"},{"key":"12508_CR46","unstructured":"Batra S, Alenfall J (1991) May-Jun;11(3):1221-4 Effect of diverse categories of drugs on human colon tumour cell proliferation. Anticancer Res. PMID: 1888153"},{"issue":"1","key":"12508_CR47","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s42003-023-04946-4","volume":"6","author":"N Clemente","year":"2023","unstructured":"Clemente N, Baroni S, Fiorilla S, Tasso F, Reano S, Borsotti C, Ruggiero MR, Alchera E, Corrazzari M, Walker G, Follenzi A, Crich SG, Carini R (2023) Boosting intracellular sodium selectively kills hepatocarcinoma cells and induces hepatocellular carcinoma tumor shrinkage in mice. Commun Biol 6(1):574. https:\/\/doi.org\/10.1038\/s42003-023-04946-4 PMID: 37248274; PMCID: PMC10227045","journal-title":"Commun Biol"},{"issue":"1","key":"12508_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12672-025-01909-5","volume":"16","author":"Q Zhu","year":"2025","unstructured":"Zhu Q, Liao S, Wei T, Liu S, Yang C, Tang J (2025) Development of a novel prognostic signature based on cytotoxic T lymphocyte-evasion genes for hepatocellular carcinoma patient management. Discov Oncol 16(1):144. https:\/\/doi.org\/10.1007\/s12672-025-01909-5 PMID: 39928212; PMCID: PMC11811355","journal-title":"Discov Oncol"},{"issue":"1","key":"12508_CR49","first-page":"197","volume":"23","author":"WH Park","year":"2003","unstructured":"Park WH, Kim ES, Kim BK, Lee YY (2003) Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis. Int J Oncol 23(1):197\u2013204 PMID: 12792794","journal-title":"Int J Oncol"},{"key":"12508_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2020.01.039","volume":"479","author":"MV Yusenko","year":"2020","unstructured":"Yusenko MV, Trentmann A, Andersson MK, Ghani LA, Jakobs A, Arteaga Paz MF, Mikesch JH, von Peter J, Stenman G, Klempnauer KH (2020) Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells. Cancer Lett 479:61\u201370 Epub 2020 Jan 31. PMID: 32014461","journal-title":"Cancer Lett"},{"key":"12508_CR51","doi-asserted-by":"publisher","unstructured":"Akin DT, Kinkade JM Jr, Parmley RT (1987) Biochemical and ultrastructural effects of monensin on the processing, intracellular transport, and packaging of myeloperoxidase into low and high density compartments of human leukemia (HL-60) cells. Arch Biochem Biophys. ;257(2):451\u2009\u2013\u200963. https:\/\/doi.org\/10.1016\/0003-9861(87)90590-x. PMID: 2821913","DOI":"10.1016\/0003-9861(87)90590-x"},{"issue":"1","key":"12508_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/08923973.2022.2112219","volume":"45","author":"C Zeng","year":"2023","unstructured":"Zeng C, Long M, Lu Y (2023) Monensin synergizes with chemotherapy in uveal melanoma through suppressing RhoA. Immunopharmacol Immunotoxicol 45(1):35\u201342 Epub 2022 Aug 31. PMID: 36043455","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"12508_CR53","doi-asserted-by":"publisher","unstructured":"Hertler AA, Schlossman DM, Borowitz MJ, Blythman HE, Casellas P, Frankel AE (1989) An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensin. Int J Cancer. ;43(2):215-9. https:\/\/doi.org\/10.1002\/ijc.2910430207. PMID: 2465276","DOI":"10.1002\/ijc.2910430207"},{"key":"12508_CR54","doi-asserted-by":"publisher","unstructured":"Park WH, Seol JG, Kim ES, Kang WK, Im YH, Jung CW, Kim BK, Lee YY (2002) Monensin-mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis. Br J Haematol. ;119(2):400-7. https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03834.x. PMID: 12406077","DOI":"10.1046\/j.1365-2141.2002.03834.x"},{"issue":"7","key":"12508_CR55","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.2024.285826","volume":"110","author":"A Torun","year":"2025","unstructured":"Torun A, Zdanowicz A, Miazek-Zapala N, Zapala P, Pradhan B, Jedrzejczyk M, Ciechanowicz A, Pilch Z, Skorzynski M, S\u0142abicki M, Rymkiewicz G, Barankiewicz J, Martines C, Laurenti L, Struga M, Winiarska M, Golab J, Kucia M, Ratajczak MZ, Huczynski A, Calado DP, Efremov DG, Zerrouqi A, Pyrzynska B (2025) Potassium\/sodium cation carriers robustly upregulate CD20 antigen by targeting MYC, and synergize with anti- CD20 immunotherapies to eliminate malignant B cells. Haematologica 110(7):1555\u20131572. https:\/\/doi.org\/10.3324\/haematol.2024.285826 Epub 2024 Dec 19. PMID: 39704178; PMCID: PMC12208165","journal-title":"Haematologica"},{"key":"12508_CR56","doi-asserted-by":"publisher","unstructured":"Di Virgilio S, Rampelberg M, Greimers R, Schnek G, Hooghe R (1992) The effects of monensin on blood-borne arrest and glycosylation of BL\/VL3 lymphoma cells. Cell Biochem Funct. ;10(1):41\u201352. https:\/\/doi.org\/10.1002\/cbf.290100108. PMID: 1349514","DOI":"10.1002\/cbf.290100108"},{"issue":"9","key":"12508_CR57","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1080\/15548627.2020.1821546","volume":"17","author":"TD Steinmetz","year":"2021","unstructured":"Steinmetz TD, Schl\u00f6tzer-Schrehardt U, Hearne A, Schuh W, Wittner J, Schulz SR, Winkler TH, J\u00e4ck HM, Mielenz D (2021) TFG is required for autophagy flux and to prevent endoplasmic reticulum stress in CH12 B lymphoma cells. Autophagy 17(9):2238\u20132256 Epub 2020 Sep 22. PMID: 32910713; PMCID: PMC8496724","journal-title":"Autophagy"},{"key":"12508_CR58","doi-asserted-by":"publisher","unstructured":"Augustine EC, Kensinger RS (1990) Endocytosis and degradation of ovine prolactin by Nb2 lymphoma cells: characterization and effects of agents known to alter prolactin-induced mitogenesis. Endocrinology. ;127(1):200\u2009\u2013\u200910. https:\/\/doi.org\/10.1210\/endo-127-1-200. PMID: 2113865","DOI":"10.1210\/endo-127-1-200"},{"key":"12508_CR59","doi-asserted-by":"publisher","unstructured":"Van Der Luit AH, Budde M, Verheij M, Van Blitterswijk WJ (2003) Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholine. Biochem J. ;374(Pt 3):747\u2009\u2013\u200953. https:\/\/doi.org\/10.1042\/BJ20030179. PMID: 12837133; PMCID: PMC1223649","DOI":"10.1042\/BJ20030179"},{"issue":"1","key":"12508_CR60","doi-asserted-by":"publisher","first-page":"17914","DOI":"10.1038\/s41598-018-36214-5","volume":"8","author":"X Wang","year":"2018","unstructured":"Wang X, Wu X, Zhang Z, Ma C, Wu T, Tang S, Zeng Z, Huang S, Gong C, Yuan C, Zhang L, Feng Y, Huang B, Liu W, Zhang B, Shen Y, Luo W, Wang X, Liu B, Lei Y, Ye Z, Zhao L, Cao D, Yang L, Chen X, Haydon RC, Luu HH, Peng B, Liu X, He TC (2018) Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway. Sci Rep 8(1):17914. https:\/\/doi.org\/10.1038\/s41598-018-36214-5 PMID: 30559409; PMCID: PMC6297164","journal-title":"Sci Rep"},{"issue":"2","key":"12508_CR61","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/cancers12020495","volume":"12","author":"D P\u00e1dua","year":"2020","unstructured":"P\u00e1dua D, Barros R, Amaral AL, Mesquita P, Freire AF, Sousa M, Maia AF, Caiado I, Fernandes H, Pombinho A, Pereira CF, Almeida R (2020) A SOX2 Reporter System Identifies Gastric Cancer Stem-Like Cells Sensitive to Monensin. Cancers (Basel) 12(2):495. https:\/\/doi.org\/10.3390\/cancers12020495 PMID: 32093282; PMCID: PMC7072720","journal-title":"Cancers (Basel)"},{"key":"12508_CR62","doi-asserted-by":"crossref","unstructured":"Tokui T, Takatori T, Shinozaki N, Ishigami M, Shiraishi A, Ikeda T, Tsuruo T (1995) Delivery and cytotoxicity of RS-1541 in St-4 human gastric cancer cells in vitro by the low-density-lipoprotein pathway. Cancer Chemother Pharmacol. ;36(1):1\u20136. doi: 10.1007\/BF00685724. PMID: 7720169","DOI":"10.1007\/BF00685724"},{"issue":"6","key":"12508_CR63","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3892\/etm.2021.10826","volume":"22","author":"S Yao","year":"2021","unstructured":"Yao S, Wang W, Zhou B, Cui X, Yang H, Zhang S (2021) Monensin suppresses cell proliferation and invasion in ovarian cancer by enhancing MEK1 SUMOylation. Exp Ther Med 22(6):1390. https:\/\/doi.org\/10.3892\/etm.2021.10826 Epub 2021 Sep 30. PMID: 34650638; PMCID: PMC8506924","journal-title":"Exp Ther Med"},{"key":"12508_CR64","doi-asserted-by":"publisher","first-page":"17523","DOI":"10.1038\/srep17523","volume":"5","author":"Y Deng","year":"2015","unstructured":"Deng Y, Zhang J, Wang Z, Yan Z, Qiao M, Ye J, Wei Q, Wang J, Wang X, Zhao L, Lu S, Tang S, Mohammed MK, Liu H, Fan J, Zhang F, Zou Y, Liao J, Qi H, Haydon RC, Luu HH, He TC, Tang L (2015) Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells. Sci Rep 5:17523. https:\/\/doi.org\/10.1038\/srep17523 PMID: 26639992; PMCID: PMC4671000","journal-title":"Sci Rep"},{"issue":"1","key":"12508_CR65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4046\/trd.2013.75.1.9","volume":"75","author":"HS Choi","year":"2013","unstructured":"Choi HS, Jeong EH, Lee TG, Kim SY, Kim HR, Kim CH (2013) Autophagy Inhibition with Monensin Enhances Cell Cycle Arrest and Apoptosis Induced by mTOR or Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cells. Tuberc Respir Dis (Seoul) 75(1):9\u201317 Epub 2013 Jul 31. PMID: 23946753; PMCID: PMC3741474","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"3","key":"12508_CR66","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbrc.2020.06.077","volume":"529","author":"K Ochi","year":"2020","unstructured":"Ochi K, Suzawa K, Tomida S, Shien K, Takano J, Miyauchi S, Takeda T, Miura A, Araki K, Nakata K, Yamamoto H, Okazaki M, Sugimoto S, Shien T, Yamane M, Azuma K, Okamoto Y, Toyooka S (2020) Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer. Biochem Biophys Res Commun 529(3):760\u2013765. https:\/\/doi.org\/10.1016\/j.bbrc.2020.06.077 Epub 2020 Jul 19. PMID: 32736704","journal-title":"Biochem Biophys Res Commun"},{"key":"12508_CR67","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-2121-10-84","volume":"10","author":"BM Chung","year":"2009","unstructured":"Chung BM, Raja SM, Clubb RJ, Tu C, George M, Band V, Band H (2009) Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src. BMC Cell Biol 10:84. https:\/\/doi.org\/10.1186\/1471-2121-10-84 PMID: 19948031; PMCID: PMC2790444","journal-title":"BMC Cell Biol"},{"key":"12508_CR68","doi-asserted-by":"publisher","unstructured":"Cleary I, Doherty G, Moran E, Clynes M (1997) The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem Pharmacol. ;53(10):1493\u2009\u2013\u2009502. https:\/\/doi.org\/10.1016\/s0006-2952(97)00003-8. PMID: 9260877","DOI":"10.1016\/s0006-2952(97)00003-8"},{"issue":"4","key":"12508_CR69","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3892\/or.2018.6247","volume":"39","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Liu Q, Dai X, Yan Y, Yang Y, Li H, Zhou X, Gao W, Li X, Xi Z (2018) Transdifferentiation of type II alveolar epithelial cells induces reactivation of dormant tumor cells by enhancing TGF-\u03b21\/SNAI2 signaling. Oncol Rep 39(4):1874\u20131882. https:\/\/doi.org\/10.3892\/or.2018.6247 Epub 2018 Feb 6. PMID: 29436661","journal-title":"Oncol Rep"},{"key":"12508_CR70","doi-asserted-by":"publisher","unstructured":"Mastroianni A, Invernizzi L, Tagliabue E, Fassina G, Albini A, M\u00e9nard S, Colnaghi MI (1993) Alteration of laminin production in small-cell lung carcinoma: possible correlation with the absence of the basement membrane. Tumour Biol. ;14(5):279\u2009\u2013\u200987. https:\/\/doi.org\/10.1159\/000217840. PMID: 8235307","DOI":"10.1159\/000217840"},{"issue":"3","key":"12508_CR71","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/bjc.1992.294","volume":"66","author":"EJ Derbyshire","year":"1992","unstructured":"Derbyshire EJ, Henry RV, Stahel RA, Wawrzynczak EJ (1992) Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines. Br J Cancer 66(3):444\u2013451. https:\/\/doi.org\/10.1038\/bjc.1992.294 PMID: 1325825; PMCID: PMC1977953","journal-title":"Br J Cancer"},{"key":"12508_CR72","doi-asserted-by":"publisher","first-page":"113440","DOI":"10.1016\/j.biopha.2022.113440","volume":"153","author":"A Urbaniak","year":"2022","unstructured":"Urbaniak A, Reed MR, Heflin B, Gaydos J, Pi\u00f1a-Oviedo S, J\u0119drzejczyk M, Klejborowska G, St\u0119pczy\u0144ska N, Chambers TC, Tackett AJ, Rodriguez A, Huczy\u0144ski A, Eoff RL, MacNicol AM (2022) Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer. Biomed Pharmacother 153:113440 Epub 2022 Jul 20. PMID: 36076555; PMCID: PMC9472755","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"12508_CR73","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bbrc.2020.05.057","volume":"530","author":"W Wan","year":"2020","unstructured":"Wan W, Zhang X, Huang C, Chen L, Yang X, Bao K, Peng T (2020) Monensin inhibits glioblastoma angiogenesis via targeting multiple growth factor receptor signaling. Biochem Biophys Res Commun 530(2):479\u2013484. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.057 Epub 2020 Jun 25. PMID: 32595038","journal-title":"Biochem Biophys Res Commun"},{"key":"12508_CR74","doi-asserted-by":"publisher","unstructured":"Ko M, Makena MR, Schiapparelli P, Suarez-Meade P, Mekile AX, Lal B, Lopez-Bertoni H, Kozielski KL, Green JJ, Laterra J, Qui\u00f1ones-Hinojosa A, Rao R (2022) The endosomal pH regulator NHE9 is a driver of stemness in glioblastoma. PNAS Nexus. ;1(1):pgac013. https:\/\/doi.org\/10.1093\/pnasnexus\/pgac013. Erratum in: PNAS Nexus. 2024;3(1):pgad456. doi: 10.1093\/pnasnexus\/pgad456. PMID: 35387234; PMCID: PMC8974362","DOI":"10.1093\/pnasnexus\/pgac013"},{"key":"12508_CR75","doi-asserted-by":"publisher","unstructured":"Schraen-Maschke S, Zanetta JP Role of oligomannosidic N-glycans in the proliferation, adhesion and signalling of C6 glioblastoma cells. Biochimie. 2003 Jan-Feb;85(1\u20132):219\u2009\u2013\u200929. https:\/\/doi.org\/10.1016\/s0300-9084(03)00018-x. PMID: 12765791","DOI":"10.1016\/s0300-9084(03)00018-x"},{"key":"12508_CR76","doi-asserted-by":"publisher","unstructured":"Basque J, Martel M, Leduc R, Cantin AM (2008) Lysosomotropic drugs inhibit maturation of transforming growth factor-beta. Can J Physiol Pharmacol. ;86(9):606\u2009\u2013\u200912. https:\/\/doi.org\/10.1139\/y08-063. PMID: 18758509","DOI":"10.1139\/y08-063"},{"issue":"16","key":"12508_CR77","doi-asserted-by":"publisher","first-page":"11721","DOI":"10.1016\/S0021-9258(17)32632-7","volume":"269","author":"RV Benya","year":"1994","unstructured":"Benya RV, Kusui T, Shikado F, Battey JF, Jensen RT (1994) Desensitization of neuromedin B receptors (NMB-R) on native and NMB-R-transfected cells involves down-regulation and internalization. J Biol Chem 269(16):11721\u201311728 PMID: 8163469","journal-title":"J Biol Chem"},{"key":"12508_CR78","doi-asserted-by":"publisher","first-page":"e7354","DOI":"10.7717\/peerj.7354","volume":"7","author":"H Xin","year":"2019","unstructured":"Xin H, Li J, Zhang H, Li Y, Zeng S, Wang Z, Zhang Z, Deng F (2019) Monensin may inhibit melanoma by regulating the selection between differentiation and stemness of melanoma stem cells. PeerJ 7:e7354. https:\/\/doi.org\/10.7717\/peerj.7354 PMID: 31380151; PMCID: PMC6661142","journal-title":"PeerJ"},{"key":"12508_CR79","doi-asserted-by":"publisher","unstructured":"Fukao H, Ueshima S, Sakai T, Okada K, Matsuo O (1989) Effect of monensin on secretion of t-PA from melanoma (Bowes). Cell Struct Funct. ;14(6):673\u2009\u2013\u200984. https:\/\/doi.org\/10.1247\/csf.14.673. PMID: 2516782","DOI":"10.1247\/csf.14.673"},{"key":"12508_CR80","doi-asserted-by":"publisher","unstructured":"Saeki H, Oikawa A (1985) Stimulation by ionophores of tyrosinase activity of mouse melanoma cells in culture. J Invest Dermatol. ;85(5):423-5. https:\/\/doi.org\/10.1111\/1523-1747.ep12277091. PMID: 3932522","DOI":"10.1111\/1523-1747.ep12277091"},{"issue":"12","key":"12508_CR81","first-page":"3496","volume":"48","author":"JA Roth","year":"1988","unstructured":"Roth JA, Ames RS, Fry K, Lee HM, Scannon PJ (1988) Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice. Cancer Res 48(12):3496\u20133501 PMID: 3259469","journal-title":"Cancer Res"},{"issue":"10","key":"12508_CR82","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s11626-018-0298-7","volume":"54","author":"SP Verma","year":"2018","unstructured":"Verma SP, Das P (2018) Monensin induces cell death by autophagy and inhibits matrix metalloproteinase 7 (MMP7) in UOK146 renal cell carcinoma cell line. Vitro Cell Dev Biol Anim 54(10):736\u2013742. https:\/\/doi.org\/10.1007\/s11626-018-0298-7 Epub 2018 Oct 15. PMID: 30324243","journal-title":"Vitro Cell Dev Biol Anim"},{"issue":"4","key":"12508_CR83","first-page":"855","volume":"22","author":"WH Park","year":"2003","unstructured":"Park WH, Jung CW, Park JO, Kim K, Kim WS, Im YH, Lee MH, Kang WK, Park K (2003) Monensin inhibits the growth of renal cell carcinoma cells via cell cycle arrest or apoptosis. Int J Oncol 22(4):855\u2013860 PMID: 12632079","journal-title":"Int J Oncol"},{"key":"12508_CR84","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3389\/fgene.2020.00810","volume":"11","author":"GF Xiao","year":"2020","unstructured":"Xiao GF, Yan X, Chen Z, Zhang RJ, Liu TZ, Hu WL (2020) Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database. Front Genet 11:810 PMID: 33014010; PMCID: PMC7461880","journal-title":"Front Genet"},{"key":"12508_CR85","doi-asserted-by":"publisher","first-page":"1288724","DOI":"10.3389\/fonc.2024.1288724","volume":"14","author":"PK Puvvula","year":"2024","unstructured":"Puvvula PK, Martinez-Medina L, Cinar M, Feng L, Pisarev A, Johnson A, Bernal-Mizrachi L (2024) A retrotransposon-derived DNA zip code internalizes myeloma cells through Clathrin-Rab5a-mediated endocytosis. Front Oncol 14:1288724. https:\/\/doi.org\/10.3389\/fonc.2024.1288724 PMID: 38463228; PMCID: PMC10920344","journal-title":"Front Oncol"},{"key":"12508_CR86","doi-asserted-by":"publisher","unstructured":"Pooley L, Shakur Y, Rena G, Houslay MD (1997) Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines. Biochem J. ;321 (Pt 1)(Pt 1):177\u2009\u2013\u200985. https:\/\/doi.org\/10.1042\/bj3210177. PMID: 9003417; PMCID: PMC1218052","DOI":"10.1042\/bj3210177"},{"issue":"2","key":"12508_CR87","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ejpb.2008.06.004","volume":"70","author":"VE Plattner","year":"2008","unstructured":"Plattner VE, Wagner M, Ratzinger G, Gabor F, Wirth M (2008) Targeted drug delivery: binding and uptake of plant lectins using human 5637 bladder cancer cells. Eur J Pharm Biopharm 70(2):572\u2013576. https:\/\/doi.org\/10.1016\/j.ejpb.2008.06.004 Epub 2008 Jun 17. PMID: 18602465","journal-title":"Eur J Pharm Biopharm"},{"key":"12508_CR88","doi-asserted-by":"publisher","unstructured":"Gamou S, Hirai M, Rikimaru K, Enomoto S, Shimizu N (1988) Biosynthesis of the epidermal growth factor receptor in human squamous cell carcinoma lines: secretion of the truncated receptor is not common to epidermal growth factor receptor-hyperproducing cells. Cell Struct Funct. ;13(1):25\u201338. https:\/\/doi.org\/10.1247\/csf.13.25. PMID: 3131023","DOI":"10.1247\/csf.13.25"},{"key":"12508_CR89","unstructured":"Orr RB, Kamen BA (1994) UMSCC38 cells amplified at 11q13 for the folate receptor synthesize a mutant nonfunctional folate receptor. Cancer Res. ;54(14):3905-11. PMID: 8033114"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12508-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12508-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12508-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:06:17Z","timestamp":1785438377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12508-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12508"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12508-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"11 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a literature review and does not contain any studies involving human participants or animals performed by the author.","order":2,"name":"Ethics","label":"Statement of ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No human participants were involved in this study.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1304"}}